Why is postpartum psychosis central in the Lindsay Clancy trial?
bbc - Lindsay Clancy's defence argues that Clancy was suffering from postpartum psychosis when she killed her children. She has pleaded not guilty to murder.
AI Summary: In the high-profile Lindsay Clancy murder trial, experts and family testimonies focused on postpartum psychosis as a central issue, examining whether the condition influenced actions. Court proceedings featured medical explanations and witness accounts debating culpability and diminished responsibility, spotlighting challenges at the crossroads of psychiatric illness and criminal law — messy and tragic.
Alibaba’s TSMC-Built 5nm RISC-V Chip, XuanTie C950, Now Runs Qwen-3.8 27B Model Natively, Unlocking Massive Vertical Integration Tailwinds
Rohail Saleem / wccftech - Alibaba appears to be emulating NVIDIA's well-established vertical integration playbook by bringing day-zero support for its highly capable Qwen-3.8 27B AI model - one that can run on just 32GB of VRAM - to its bespoke RISC-V chip, called XuanTie C950. Al…
AI Summary: Harold P. Freeman, the architect of patient navigation and a tireless advocate for health equity in cancer care, has died at 93. Colleagues and organizations remember his decades of work reducing barriers to treatment, mentoring leaders, and reshaping how underserved patients access timely cancer services.
What cannabis use really tells us about university students’ eating habits
Jamie Seabrook, Professor, Department of Epidemiology and Biostatistics; Professor, Department of Pa / theconversation - Researchers surveyed more than 1,500 students at a large Canadian university to better understand the relationship between cannabis use and diet quality.
AI Summary: Research examining university students finds cannabis use associates with distinct eating behaviours and dietary patterns, illuminating links between substance use and nutrition among young adults. The results suggest a role for integrated health messaging and campus support that addresses both substance use and dietary consequences.
Nearly 7 in 10 patients view test results before a clinician weighs in: Study
Paige Twenter / beckershospitalreview - Nearly 7 in 10 patients view their test results online before a clinician contacts them to explain, according to a study published Aug. 18 in JAMA Network Open. The study drew on 4,982 respondents to the 2024 “Health Information National Trends Survey,” a…
AI Summary: A study finds nearly seven in ten patients access their lab and test results via portals before a clinician has had a chance to interpret them, increasing risk of misunderstanding and anxiety. Authors urge clearer timing policies and improved communication to balance transparency with the need for clinical context.
UHS closes $835M Talkspace acquisition, creating end-to-end behavioral health continuum
Andrew Cass / beckershospitalreview - King of Prussia, Pa.-based Universal Health Services has completed its acquisition of online behavioral health provider Talkspace in a deal valued at about $835 million. UHS and Talkspace first announced the deal in March and have now received all necessa…
AI Summary: UnitedHealth Services closed its $835 million acquisition of Talkspace, folding the virtual therapy platform into a broader behavioral-health strategy to expand access and create an end-to-end care continuum. The move accelerates digital mental-health integration at scale, promising greater capacity but also sparking debate about consolidation's effects on competition, quality, and clinician autonomy.
County surveillance failed to detect that measles transmission reached epidemic threshold in schools
nature - Nature Medicine, Published online: 20 August 2026; doi:10.1038/s41591-026-04612-2A nationwide analysis of measles vaccination records from more than 50,000 US schools shows that measles transmission risk crossed the threshold that can lead to epidemics at…
AI Summary: A new analysis found county-level vaccination and surveillance figures can mask concentrated measles transmission within particular schools and districts, allowing outbreaks to meet epidemic thresholds undetected. Researchers warn that aggregated data obscure local hotspots, hampering targeted vaccination and school-based interventions needed to stop spread before it becomes a community problem.
Ousted system CEO sues OHSU, alleges retaliation
Kristin Kuchno / beckershospitalreview - Tarek Salaway, who served as CEO of Portland-based OHSU Health Care for less than four months before being terminated in April, has filed a $15.5 million lawsuit against Oregon Health & Science University, The Oregonian reported Aug. 17. Mr. Salaway filed…
AI Summary: The former CEO of OHSU Healthcare has filed a lawsuit alleging wrongful termination, discrimination and retaliatory conduct by the health system. The complaint seeks remedies and places organizational governance and personnel decisions under legal scrutiny, promising protracted courtroom debate over internal management practices and the circumstances surrounding the leadership exit.
How Louisiana’s New Surgeon General Wants To Transform Public Health
Rosemary Westwood, The New York Times / kffhealthnews - Evelyn Griffin is pushing for more emphasis on wellness and prevention. She has also aligned with the MAHA movement in fighting government mandates and questioning the safety of some vaccines.
AI Summary: Louisiana’s new surgeon general outlined an ambitious agenda to revamp public health, prioritizing prevention, health equity and system reforms to tackle chronic disease and access gaps. The plan emphasizes community engagement, measurable targets and pragmatic policy levers—basically, less brochure writing and more fixing the plumbing of a beleaguered health system.
Charles Roberts Named the Next President and CEO of St. Jude Children’s Research Hospital
oncodaily - Charles Roberts, Current Cancer Center Director and Executive Vice-President and Next President and CEO of St. Jude Children’s Research Hospital, shared St. Jude Children’s Research Hospital’s post on LinkedIn, adding: […]
AI Summary: Charles Roberts was named president and CEO of St. Jude Children’s Research Hospital, stepping into leadership of a globally recognized pediatric cancer and research institution. He’ll oversee strategy, fundraising and clinical priorities as the center pursues ambitious research and care goals — and deal with the inevitable complexity of running a world-class nonprofit hospital.
AI may know how you’ll respond to a vaccine before you get it
sciencedaily - AI may be able to predict how strongly someone will respond to a vaccine before they receive it. By analyzing antibody patterns in more than 4,000 people, researchers found signs of “immune readiness” that helped distinguish strong responders from weak on…
AI Summary: Researchers report AI models that can forecast individual immune responses to vaccines by identifying predictive biological signatures. These tools could enable personalized vaccination strategies and smarter trial design, although real‑world validation and ethical deployment remain necessary before clinics trade one‑size‑fits‑all jabs for algorithmic matchmaking.
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
oncodaily - The U.S. Food and Drug Administration (FDA) has listed more than 1,500 artificial intelligence-enabled medical devices authorized for marketing in the United States, reflecting the growing integration of AI across […]
AI Summary: The FDA catalogued more than 1,500 AI‑enabled medical devices, spurring criticism that most were cleared without direct evidence they improve patient outcomes. Regulators and clinicians face mounting calls for post‑market studies and transparency, balancing enthusiasm for AI innovation against the sober question: do these devices actually help patients?
Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease
Frank Vinluan / medcitynews - Ultragenyx Pharmaceutical’s Genglycos received accelerated FDA approval for glycogen storage disease type Ia, an inherited enzyme deficiency. It’s also the first approved gene therapy for Ultragenyx, which specializes in rare disease treatments. The post …
AI Summary: Ultragenyx received FDA approval for a gene therapy, marking the first approved treatment for that particular ultra‑rare disorder. The decision provides a regulated therapeutic option for patients previously without approved care, highlighting the evolving regulatory willingness to greenlight transformative but small‑population medicines.
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
oncodaily - Treatment intensification with androgen receptor pathway inhibitors has become central to the management of metastatic hormone-sensitive prostate cancer (mHSPC). However, as patients remain on these therapies for years, longer follow-up […]
AI Summary: Long-term follow-up from ENZAMET shows enzalutamide continues to deliver a substantial overall survival benefit at eight years for patients with metastatic hormone-sensitive prostate cancer. The durable outcome cements enzalutamide’s role in combination androgen-deprivation strategies, giving patients and clinicians a proven option — not a cure, but progress that actually lasts.
R1 drills down on AI prior authorizations with Humata buy
Jill Hughes / healthcaredive - The revenue cycle company wants to automate claims processing, and RI is banking that Humata’s track record of streamlining medical preapprovals should help further that goal.
AI Summary: R1 has moved to buy Humata Health, folding AI-driven prior authorization tools into its revenue-cycle stack. The acquisition targets faster, more automated approval workflows for payers and providers, promising efficiency gains — and the usual question: will automation fix paperwork or just rebrand it as “innovation”?
Cityblock inks deal to acquire Homeward Health to move into rural healthcare, lands $116M funding round
fiercehealthcare - Combined, the two companies will serve nearly 250,000 people and are positioned to reach the120 million people receiving government-funded healthcare in the U.S., Toyin Ajayi, Cityblock Health CEO and co-founder wrote in a blog post.
AI Summary: Cityblock Health has acquired Homeward Health, signaling a strategic push into rural Medicare services backed by fresh funding. The deal aims to blend Cityblock’s value-based, whole-person care model with Homeward’s rural footprint, promising expanded access — and yes, more venture-capital-fueled disruption in places that actually need care.
Bedbugs can cause people to lose sleep—and blood. Here's what to do about them
medicalxpress - Bedbugs are sometimes called the vampires of the insect world—hiding during the day and coming out at night to feast on human blood. Generations of children have been told: "Sleep tight. Don't let the bedbugs bite."
AI Summary: Reports describe bedbug infestations that not only wreck sleep but can cause significant blood loss and anemia in vulnerable people. Health experts recommend inspection, targeted pest control, laundering and supportive care for affected residents, while warning that stigma and slow public-health responses let infestations fester. Practical, not panicky, measures are urged.
Anas Younes: Decade-Long Persistence of CD19 CAR T Cells in B Cell Lymphomas
oncodaily - Anas Younes, Chief Medical Officer and Head of Haematology R&D at AstraZeneca, shared on LinkedIn: “While these findings demonstrate that CART19 cells can persist for more than 10 years in […]
AI Summary: Long-term follow-up shows CD19-directed CAR‑T cells can persist for a decade in patients with B‑cell lymphomas, associating with sustained remissions and reshaping expectations about durability, retreatment and long-term toxicity. These findings prompt rethinking of follow-up care and suggest cellular therapies may offer far longer benefits than anyone dared hope.
ASTRO updates guideline on radiation therapy for pancreatic cancer
medicalxpress - An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.
AI Summary: ASTRO released updated 2026 guidance for radiation therapy in pancreatic cancer, refining target volumes, dose constraints, and technique recommendations. The update aims to standardize practice, improve safety for nearby organs at risk, and incorporate emerging evidence on hypofractionation and concurrent systemic therapies to better balance local control with toxicity.
Calls for Forests Minister Ravi Parmar to resign intensify amid wildfire crisis
Alex Zoltan / westernstandard - PENTICTON — The Conservative Party of BC, and others, are intensifying calls for Forests Minister Ravi Parmar to resign, citing multiple mill closures that cost hundreds of high-paying jobs and the government’s handling of a destructive wildfire season th…
AI Summary: A four‑part investigative series explores pre‑surgical complications, documenting common causes, system shortcomings, and patient experiences. The reporting synthesizes clinical evidence and expert commentary to recommend perioperative safeguards, communication improvements, and policy changes designed to reduce avoidable harm and improve surgical outcomes.
- Imaging and tech reshaping surgical planning (4)
- Pre-op optimization and outcome drivers (4)
- Safety culture, decisions and system failures (3)
- All Other Stories
Imaging and tech reshaping surgical planning
Pre-op optimization and outcome drivers
Safety culture, decisions and system failures
All Other Stories
Essentia Health names EVP from SSM Health
Kelly Gooch / beckershospitalreview - Jason Craig, most recently a regional vice president at St. Louis-based SSM Health, was named executive vice president of administration and operations at Duluth, Minn.-based Essentia Health, according to an Aug. 12 news release shared with Becker’s. Mr. …
AI Summary: Recent analyses and expert commentary propose that genomic newborn screening can identify children with cancer predisposition syndromes before tumors develop. Early detection would enable targeted surveillance and preventive measures, though ethical, logistical, and equity considerations remain central to implementing such programs at scale. Expect lively debate before universal adoption.